19 For women with breast cancer enrolled in commercial US plans, there was an increasing trend in gene expression profiling panels from 2.2% in 2006 to 18.8% in 2012. 20 Although not specifically NGS testing, gene expression profiling provides an analogy to adoption rates of NGS panels.
← all excerpts
Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans.
1
—
—